TSPY21P

Q-omics provides the consensus-scored TSPY21P profile across patient tissues and cancer cell-line models. TSPY21P expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in COAD. Additionally, TSPY21P RNA expression shows 101 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight COAD, and ESCA as cancer lineages where TSPY21P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes TSPY21P survival associations across molecular data types. TSPY21P RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

TSPY21P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	COAD (72)	view →

This table ranks reproducible TSPY21P RNA expression–survival associations across cancer types. High TSPY21P expression shows unfavorable associations in COAD and LIHC. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify COAD as the clearest survival context for TSPY21P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.035	0.791	<.001	72	view →
LIHC	OS	Tertile	All	0.152	0.688	.017	27	view →

Pink = unfavorable, green = favorable. all 2 lineages →

TSPY21P-COAD (DFS)

Explore this curve interactively →